401 related articles for article (PubMed ID: 33608902)
1. Association of different Candida species with catheter-related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm-forming capabilities.
Zuo XS; Liu Y; Cai X; Zhan L; Hu K
J Clin Lab Anal; 2021 Apr; 35(4):e23738. PubMed ID: 33608902
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
Aslan H; Gülmez D
Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
[TBL] [Abstract][Full Text] [Related]
3. Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.
Marcos-Zambrano LJ; Puig-Asensio M; Pérez-García F; Escribano P; Sánchez-Carrillo C; Zaragoza O; Padilla B; Cuenca-Estrella M; Almirante B; Martín-Gómez MT; Muñoz P; Bouza E; Guinea J
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438935
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures.
Sriphannam C; Nuanmuang N; Saengsawang K; Amornthipayawong D; Kummasook A
J Mycol Med; 2019 Dec; 29(4):325-330. PubMed ID: 31447236
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates.
Thomaz DY; Melhem MSC; de Almeida Júnior JN; Benard G; Del Negro GMB
Braz J Microbiol; 2020 Sep; 51(3):1129-1133. PubMed ID: 31898245
[TBL] [Abstract][Full Text] [Related]
8. A study on Candida biofilm growth characteristics and its susceptibility to aureobasidin A.
Munusamy K; Vadivelu J; Tay ST
Rev Iberoam Micol; 2018; 35(2):68-72. PubMed ID: 29544734
[TBL] [Abstract][Full Text] [Related]
9. Role of Non Albicans Candida Spp. and Biofilm in Neonatal ICU.
Goel S; Mittal S; Chaudhary U
Infect Disord Drug Targets; 2016; 16(3):192-198. PubMed ID: 27538491
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilms.
Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J
J Antimicrob Chemother; 2016 Sep; 71(9):2498-501. PubMed ID: 27147303
[TBL] [Abstract][Full Text] [Related]
12. Association between Candida biofilm-forming bloodstream isolates and the clinical evolution in patients with candidemia: An observational nine-year single center study in Mexico.
Treviño-Rangel RJ; Peña-López CD; Hernández-Rodríguez PA; Beltrán-Santiago D; González GM
Rev Iberoam Micol; 2018; 35(1):11-16. PubMed ID: 29287632
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibility of Candida isolates at one institution.
Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J
Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093
[TBL] [Abstract][Full Text] [Related]
14. Biofilm formation by Candida auris isolated from colonising sites and candidemia cases.
Singh R; Kaur M; Chakrabarti A; Shankarnarayan SA; Rudramurthy SM
Mycoses; 2019 Aug; 62(8):706-709. PubMed ID: 31132181
[TBL] [Abstract][Full Text] [Related]
15. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
[TBL] [Abstract][Full Text] [Related]
16. Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality.
Soldini S; Posteraro B; Vella A; De Carolis E; Borghi E; Falleni M; Losito AR; Maiuro G; Trecarichi EM; Sanguinetti M; Tumbarello M
Clin Microbiol Infect; 2018 Jul; 24(7):771-777. PubMed ID: 29133157
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole inhibits biofilm formation in different species of the genus Candida.
Valentín A; Cantón E; Pemán J; Martínez JP
J Antimicrob Chemother; 2012 Oct; 67(10):2418-23. PubMed ID: 22733651
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibility and virulence determinants profile of candida species isolated from patients with candidemia.
Dawoud AM; Saied SA; Torayah MM; Ramadan AE; Elaskary SA
Sci Rep; 2024 May; 14(1):11597. PubMed ID: 38773138
[TBL] [Abstract][Full Text] [Related]
19. [Clinical pathogenesis of candidemia caused by non-albicans Candida species].
Myoken Y
Nihon Ishinkin Gakkai Zasshi; 2009; 50(4):225-8. PubMed ID: 19942793
[TBL] [Abstract][Full Text] [Related]
20. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
